Fig. 4.
Different tissue distributions of PB and BM T cells in the allogeneic recipients at 7 days after BM transplantation.
Lethally irradiated BALB/c recipients (H-2Kd) were injected with 1.5 × 106 donor C57BL/6 (H-2Kb, CD45.1) TCD BM and 500 × 103 PB CD4+/CD8+ or BM CD4+/CD8+ T cells from congenic C57BL/6 (H-2Kb, CD45.2) mice. The mononuclear cells from blood, gut, and liver of the recipients were harvested and stained with anti–H-2Kb, TCRαβ, and CD45.2 mAbs. In the first column, panels A, E, and I show the tissues from the recipients given PB CD4+/CD8+ T cells, and panels C, G, and K show the tissues from the recipients given marrow CD4+/CD8+ T cells. Analyses in panels A, C, E, G, I, and K show TCRαβ versus H-2Kb with TCRαβ+H-2Kb+ cells enclosed in boxes. In the second column, the gated TCRαβ+H2kb+cells were analyzed further for TCRαβ versus CD45.2 in panels B, D, F, H, J, and L. Each panel is representative of 4 recipients.